Symbols / GRFS Stock $8.39 +0.00% Grifols, S.A.

Healthcare • Drug Manufacturers - General • Spain • NMS
GRFS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.

Stock Fundamentals
Scroll to Statements
Market Cap 5.71B Enterprise Value 16.84B Income 402.00M Sales 7.52B Book/sh 4.56 Cash/sh 1.25
Dividend Yield 2.10% Payout 25.50% Employees 25258 IPO — P/E 11.99 Forward P/E 5.76
PEG 0.19 P/S 0.76 P/B 1.84 P/C — EV/EBITDA 9.92 EV/Sales 2.24
Quick Ratio 0.84 Current Ratio 2.51 Debt/Eq 126.83 LT Debt/Eq — EPS (ttm) 0.70 EPS next Y 1.46
EPS Growth 43.50% Revenue Growth 0.30% Earnings 2026-02-26 ROA 4.24% ROE 6.17% ROIC —
Gross Margin 38.80% Oper. Margin 17.53% Profit Margin 5.34% Shs Outstand 680.58M Shs Float 417.32M Short Float —
Short Ratio 6.26 Short Interest — 52W High 11.14 52W Low 6.90 Beta 1.21 Avg Volume 726.77K
Volume 1.04M Target Price $11.10 Recom Buy Prev Close $8.39 Price $8.39 Change 0.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$11.10
Mean price target
2. Current target
$8.39
Latest analyst target
3. DCF / Fair value
$27.11
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$8.39
Low
$10.00
High
$12.20
Mean
$11.10

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-12-08 main JP Morgan Neutral → Neutral $10
2025-06-17 main JP Morgan Neutral → Neutral $10
2024-03-12 down Deutsche Bank Hold → Sell —
2023-12-05 main JP Morgan Neutral → Neutral $11
2021-11-05 down Deutsche Bank Buy → Hold —
2021-03-23 up Credit Suisse Neutral → Outperform —
2021-03-11 up HSBC Hold → Buy —
2019-10-28 up Santander Hold → Buy —
2019-06-27 up JP Morgan Neutral → Overweight $23
2019-02-08 down Berenberg Buy → Hold —
2019-01-02 main Morgan Stanley Underweight → Underweight $19
2018-10-01 main Morgan Stanley Underweight → Underweight $20
2018-03-01 main Morgan Stanley Underweight → Underweight $22
2016-03-17 init Nomura — → Buy —
2016-02-09 up Berenberg Hold → Buy —
2016-01-04 down Morgan Stanley Equal-Weight → Underweight —
2015-12-02 down HSBC Buy → Hold —
2015-11-20 down Berenberg Buy → Hold —
2015-02-12 down Morgan Stanley Overweight → Equal-Weight —
2014-03-04 main JP Morgan Neutral → Overweight $60
News
RSS: Latest GRFS news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
7,524.00
+4.33%
7,212.00
+9.41%
6,592.00
+8.71%
6,063.97
Operating Revenue
7,281.00
+3.95%
7,004.00
+9.64%
6,388.00
+9.88%
5,813.80
Cost Of Revenue
4,665.00
+5.59%
4,418.00
+7.52%
4,109.00
+6.72%
3,850.26
Reconciled Cost Of Revenue
4,335.00
+5.94%
4,092.00
+8.54%
3,770.00
+6.88%
3,527.33
Gross Profit
2,859.00
+2.33%
2,794.00
+12.53%
2,483.00
+12.16%
2,213.71
Operating Expense
1,608.00
-1.89%
1,639.00
-7.14%
1,765.00
+15.00%
1,534.75
Research And Development
426.00
+10.94%
384.00
-2.78%
395.00
+9.38%
361.14
Selling General And Administration
1,063.00
-7.00%
1,143.00
-9.72%
1,266.00
+14.28%
1,107.79
General And Administrative Expense
1,063.00
-7.00%
1,143.00
-9.72%
1,266.00
+14.28%
1,107.79
Salaries And Wages
—
—
528.78
+11.93%
472.41
Other Gand A
1,063.00
-7.00%
1,143.00
-9.72%
1,266.00
+14.28%
1,107.79
Other Operating Expenses
-1.00
—
-3.00
+86.51%
-22.23
Total Expenses
6,273.00
+3.57%
6,057.00
+3.12%
5,874.00
+9.08%
5,385.01
Operating Income
1,251.00
+8.31%
1,155.00
+60.86%
718.00
+5.75%
678.96
Total Operating Income As Reported
1,243.00
+4.28%
1,192.00
+52.43%
782.00
-0.06%
782.44
EBITDA
1,641.00
+10.58%
1,484.00
+27.05%
1,168.00
-2.14%
1,193.54
Normalized EBITDA
1,664.00
+8.69%
1,531.00
+29.42%
1,183.00
+0.78%
1,173.81
Reconciled Depreciation
450.00
+2.74%
438.00
-1.79%
446.00
+8.52%
410.98
EBIT
1,191.00
+13.86%
1,046.00
+44.88%
722.00
-7.74%
782.56
Total Unusual Items
-23.00
+51.06%
-47.00
-213.33%
-15.00
-176.05%
19.72
Total Unusual Items Excluding Goodwill
-23.00
+51.06%
-47.00
-213.33%
-15.00
-176.05%
19.72
Special Income Charges
-3.00
+66.67%
-9.00
0.00
0.00
Write Off
3.00
-66.67%
9.00
0.00
0.00
Net Income
402.00
+156.05%
157.00
+273.81%
42.00
-77.30%
185.03
Pretax Income
615.00
+38.51%
444.00
+115.53%
206.00
-39.06%
338.01
Net Non Operating Interest Income Expense
-605.00
+13.69%
-701.00
-25.18%
-560.00
-21.04%
-462.67
Interest Expense Non Operating
576.00
-4.32%
602.00
+16.67%
516.00
+16.07%
444.54
Net Interest Income
-605.00
+13.69%
-701.00
-25.18%
-560.00
-21.04%
-462.67
Interest Expense
576.00
-4.32%
602.00
+16.67%
516.00
+16.07%
444.54
Interest Income Non Operating
34.00
-22.73%
44.00
-29.03%
62.00
+83.11%
33.86
Interest Income
34.00
-22.73%
44.00
-29.03%
62.00
+83.11%
33.86
Other Income Expense
-31.00
-210.00%
-10.00
-120.83%
48.00
-60.57%
121.72
Gain On Sale Of Security
-20.00
+47.37%
-38.00
-153.33%
-15.00
-176.05%
19.72
Tax Provision
115.00
-50.22%
231.00
+437.21%
43.00
-52.28%
90.11
Tax Rate For Calcs
0.00
-25.20%
0.00
+19.77%
0.00
-21.70%
0.00
Tax Effect Of Unusual Items
-4.30
+63.40%
-11.75
-275.27%
-3.13
-159.55%
5.26
Net Income Including Noncontrolling Interests
500.00
+134.74%
213.00
+30.67%
163.00
-34.25%
247.90
Net Income From Continuing Operation Net Minority Interest
402.00
+156.05%
157.00
+273.81%
42.00
-77.30%
185.03
Net Income From Continuing And Discontinued Operation
402.00
+156.05%
157.00
+273.81%
42.00
-77.30%
185.03
Net Income Continuous Operations
500.00
+134.74%
213.00
+30.67%
163.00
-34.25%
247.90
Minority Interests
-98.00
-75.00%
-56.00
+53.72%
-121.00
-92.47%
-62.87
Normalized Income
420.70
+118.83%
192.25
+256.88%
53.87
-68.42%
170.57
Net Income Common Stockholders
402.00
+156.05%
157.00
+273.81%
42.00
-77.30%
185.03
Diluted EPS
—
0.23
+283.33%
0.06
-80.65%
0.31
Basic EPS
—
0.23
+283.33%
0.06
-80.65%
0.31
Basic Average Shares
—
679.67
-0.01%
679.76
-0.01%
679.81
Diluted Average Shares
—
679.92
+0.02%
679.76
-0.01%
679.81
Diluted NI Availto Com Stockholders
402.00
+156.05%
157.00
+273.81%
42.00
-77.30%
185.03
Depreciation Amortization Depletion Income Statement
120.00
+7.14%
112.00
+4.67%
107.00
+21.51%
88.06
Depreciation And Amortization In Income Statement
120.00
+7.14%
112.00
+4.67%
107.00
+21.51%
88.06
Earnings From Equity Interest
-8.00
-121.62%
37.00
-41.27%
63.00
-38.23%
102.00
Gain On Sale Of PPE
—
—
-24.99
-37.32%
-18.20
Total Other Finance Cost
63.00
-55.94%
143.00
+34.91%
106.00
+103.92%
51.98
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
19,712.00
-7.91%
21,405.00
+1.97%
20,992.10
-1.12%
21,229.58
Current Assets
5,074.00
-11.42%
5,728.00
-6.57%
6,131.02
+30.71%
4,690.72
Cash Cash Equivalents And Short Term Investments
824.00
-17.68%
1,001.00
+83.84%
544.50
-6.16%
580.24
Cash And Cash Equivalents
801.00
-18.27%
980.00
+85.05%
529.58
-3.57%
549.21
Cash Equivalents
8.00
+60.00%
5.00
-23.15%
6.51
+130020.00%
0.01
Cash Financial
793.00
-18.67%
975.00
+86.40%
523.07
-4.55%
547.98
Other Short Term Investments
23.00
+9.52%
21.00
+40.69%
14.93
-51.90%
31.03
Receivables
856.00
-20.67%
1,079.00
+18.29%
912.20
+17.82%
774.20
Accounts Receivable
651.00
-7.66%
705.00
+9.28%
645.11
+5.92%
609.08
Gross Accounts Receivable
674.00
-7.16%
726.00
+7.29%
676.69
+5.57%
640.98
Allowance For Doubtful Accounts Receivable
-23.00
-9.52%
-21.00
+33.49%
-31.58
+2.21%
-32.29
Other Receivables
121.00
+128.30%
53.00
-38.33%
85.95
-20.67%
108.33
Taxes Receivable
72.00
-32.71%
107.00
+34.09%
79.80
+40.54%
56.78
Loans Receivable
12.00
-94.39%
214.00
+111.18%
101.34
+211018.75%
0.05
Inventory
3,296.00
-7.42%
3,560.00
+2.23%
3,482.40
+7.61%
3,236.01
Raw Materials
936.00
-4.39%
979.00
-10.37%
1,092.30
+2.59%
1,064.78
Work In Process
1,407.00
-4.80%
1,478.00
+22.14%
1,210.09
-9.13%
1,331.64
Finished Goods
1,052.00
-16.04%
1,253.00
+6.19%
1,180.01
+46.60%
804.94
Prepaid Assets
9.00
-10.00%
10.00
+123.46%
4.47
-76.92%
19.39
Restricted Cash
24.00
0.00
—
—
Assets Held For Sale Current
—
0.00
-100.00%
1,089.86
+21833.11%
4.97
Hedging Assets Current
0.00
-100.00%
6.00
-74.62%
23.64
+87.22%
12.63
Other Current Assets
65.00
-9.72%
72.00
-2.63%
73.94
-10.57%
82.68
Total Non Current Assets
14,638.00
-6.63%
15,677.00
+5.49%
14,861.09
-10.14%
16,538.86
Net PPE
4,052.00
-5.99%
4,310.00
+2.81%
4,192.36
-2.14%
4,284.12
Gross PPE
6,715.00
-3.38%
6,950.00
+7.45%
6,468.23
+50.98%
4,284.12
Accumulated Depreciation
-2,663.00
-0.87%
-2,640.00
-16.00%
-2,275.87
-9.24%
-2,083.45
Properties
0.00
0.00
0.00
0.00
Land And Improvements
1,209.00
-1.79%
1,231.00
+8.75%
1,131.91
-2.03%
1,155.41
Machinery Furniture Equipment
3,478.00
-3.17%
3,592.00
+11.91%
3,209.59
+3.42%
3,103.46
Construction In Progress
726.00
-9.48%
802.00
-11.93%
910.67
+3.67%
878.41
Other Properties
—
—
—
4,284.12
Leases
1,302.00
-1.74%
1,325.00
+8.96%
1,216.06
+9.10%
1,114.65
Goodwill And Other Intangible Assets
9,561.00
-7.44%
10,329.00
+7.21%
9,634.32
-3.28%
9,961.06
Goodwill
6,833.00
-7.70%
7,403.00
+8.83%
6,802.13
-2.99%
7,011.91
Other Intangible Assets
2,728.00
-6.77%
2,926.00
+3.31%
2,832.20
-3.97%
2,949.15
Investments And Advances
460.00
-13.04%
529.00
+17.06%
451.90
-77.34%
1,994.57
Long Term Equity Investment
97.00
+40.58%
69.00
-83.64%
421.76
-71.84%
1,497.96
Non Current Accounts Receivable
—
0.06
—
—
Non Current Deferred Assets
416.00
+21.64%
342.00
+13.88%
300.33
+71.69%
174.92
Non Current Deferred Taxes Assets
416.00
+21.64%
342.00
+13.88%
300.33
+71.69%
174.92
Non Current Prepaid Assets
16.00
+77.78%
9.00
+1.44%
8.87
-4.37%
9.28
Other Non Current Assets
—
137.00
+1.01%
135.63
+9.21%
124.19
Total Liabilities Net Minority Interest
12,109.00
-5.39%
12,799.00
-5.04%
13,478.41
+1.70%
13,253.45
Current Liabilities
2,019.00
-6.35%
2,156.00
-7.29%
2,325.44
+15.16%
2,019.28
Payables And Accrued Expenses
1,347.00
-1.25%
1,364.00
+12.94%
1,207.76
+31.48%
918.58
Payables
1,347.00
-1.25%
1,364.00
+12.94%
1,207.76
+31.48%
918.58
Accounts Payable
841.00
-1.29%
852.00
+3.53%
822.95
+4.44%
787.96
Other Payable
456.00
+7.04%
426.00
+22.40%
348.03
+202.83%
114.93
Employee Benefits
—
—
100.16
+6.47%
94.07
Total Tax Payable
50.00
-41.86%
86.00
+133.87%
36.77
+134.41%
15.69
Income Tax Payable
25.00
-59.02%
61.00
+320.02%
14.52
-7.42%
15.69
Current Debt And Capital Lease Obligation
523.00
-21.71%
668.00
-32.38%
987.91
+45.01%
681.27
Current Debt
410.00
-25.59%
551.00
-37.44%
880.81
+52.15%
578.92
Other Current Borrowings
410.00
-25.59%
551.00
-37.44%
880.81
+52.15%
578.92
Current Capital Lease Obligation
113.00
-3.42%
117.00
+9.24%
107.10
+4.64%
102.36
Current Deferred Liabilities
34.00
-20.93%
43.00
+9.71%
39.19
+3.59%
37.83
Current Deferred Revenue
34.00
-20.93%
43.00
+9.71%
39.19
+3.59%
37.83
Other Current Liabilities
80.00
+90.48%
42.00
-1.82%
42.78
-95.90%
1,044.36
Total Non Current Liabilities Net Minority Interest
10,090.00
-5.20%
10,643.00
-4.57%
11,152.97
-0.72%
11,234.18
Long Term Debt And Capital Lease Obligation
9,043.00
-4.26%
9,445.00
-5.41%
9,985.04
+10.10%
9,068.85
Long Term Debt
8,074.00
-4.11%
8,420.00
-6.24%
8,980.82
+10.14%
8,154.26
Long Term Capital Lease Obligation
969.00
-5.46%
1,025.00
+2.07%
1,004.23
+9.80%
914.59
Long Term Provisions
119.00
-4.80%
125.00
+6.91%
116.92
+6.23%
110.06
Non Current Pension And Other Postretirement Benefit Plans
—
—
100.16
+6.47%
94.07
Non Current Deferred Liabilities
877.00
-14.52%
1,026.00
+2.35%
1,002.44
-4.52%
1,049.95
Non Current Deferred Revenue
16.00
+14.29%
14.00
+1.40%
13.81
-8.70%
15.12
Non Current Deferred Taxes Liabilities
861.00
-14.92%
1,012.00
+2.36%
988.63
-4.46%
1,034.82
Other Non Current Liabilities
50.00
+6.38%
47.00
-3.19%
48.55
-99.52%
10,074.17
Stockholders Equity
5,271.00
-10.40%
5,883.00
+9.59%
5,368.38
-4.96%
5,648.52
Common Stock Equity
5,271.00
-10.40%
5,883.00
+9.59%
5,368.38
-4.96%
5,648.52
Capital Stock
120.00
+0.00%
120.00
+0.33%
119.60
+0.00%
119.60
Common Stock
120.00
+0.00%
120.00
+0.33%
119.60
+0.00%
119.60
Share Issued
687.55
+0.00%
687.55
+0.00%
687.55
+0.00%
687.55
Ordinary Shares Number
680.58
+0.02%
680.41
+0.19%
679.09
+0.10%
678.41
Treasury Shares Number
6.98
-2.33%
7.15
-15.56%
8.46
-7.45%
9.14
Additional Paid In Capital
911.00
+0.00%
911.00
+0.03%
910.73
+0.00%
910.73
Retained Earnings
300.00
+91.08%
157.00
+271.00%
42.32
0.00
Gains Losses Not Affecting Retained Earnings
4,071.00
-15.71%
4,830.00
+8.58%
4,448.47
-6.94%
4,780.41
Treasury Stock
131.00
-2.96%
135.00
-11.62%
152.75
-5.84%
162.22
Minority Interest
2,332.00
-14.36%
2,723.00
+26.93%
2,145.32
-7.83%
2,327.61
Other Equity Adjustments
4,179.00
+3.31%
4,045.00
+0.26%
4,034.36
-0.25%
4,044.63
Total Equity Gross Minority Interest
7,603.00
-11.65%
8,606.00
+14.54%
7,513.69
-5.80%
7,976.13
Total Capitalization
13,345.00
-6.70%
14,303.00
-0.32%
14,349.19
+154.03%
5,648.52
Working Capital
3,055.00
-14.47%
3,572.00
-6.14%
3,805.57
+42.45%
2,671.45
Invested Capital
13,755.00
-7.40%
14,854.00
-2.47%
15,230.00
+169.63%
5,648.52
Total Debt
9,566.00
-5.41%
10,113.00
-7.84%
10,972.95
+12.54%
9,750.12
Net Debt
7,683.00
-3.85%
7,991.00
-14.37%
9,332.05
+14.01%
8,185.20
Capital Lease Obligations
1,082.00
-5.25%
1,142.00
+2.76%
1,111.33
+9.28%
1,016.94
Net Tangible Assets
-4,290.00
+3.51%
-4,446.00
-4.22%
-4,265.95
+1.08%
-4,312.53
Tangible Book Value
-4,290.00
+3.51%
-4,446.00
-4.22%
-4,265.95
+1.08%
-4,312.53
Available For Sale Securities
361.00
-20.66%
455.00
+1410.27%
30.13
-93.93%
496.61
Current Provisions
35.00
-10.26%
39.00
-18.42%
47.81
-15.15%
56.34
Derivative Product Liabilities
1.00
0.00
-100.00%
0.01
-99.73%
4.00
Financial Assets
0.00
-100.00%
1.00
-4.12%
1.04
-96.14%
27.03
Financial Assets Designatedas Fair Value Through Profitor Loss Total
2.00
-60.00%
5.00
+71328.57%
0.01
—
Foreign Currency Translation Adjustments
-10.00
-101.25%
803.00
+93.91%
414.11
-43.72%
735.78
Inventories Adjustments Allowances
-99.00
+34.00%
-150.00
—
—
Investmentin Financial Assets
363.00
-21.09%
460.00
+1426.51%
30.13
-93.93%
496.61
Non Current Note Receivables
133.00
+565.00%
20.00
-85.36%
136.63
+24.55%
109.70
Unrealized Gain Loss
-98.00
-444.44%
-18.00
0.00
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
1,047.00
+16.08%
902.00
+315.67%
217.00
+15306.73%
-1.43
Cash Flow From Continuing Operating Activities
1,047.00
+16.08%
902.00
+315.67%
217.00
+15306.73%
-1.43
Net Income From Continuing Operations
615.00
+38.51%
444.00
+115.53%
206.00
-39.06%
338.01
Depreciation Amortization Depletion
450.00
+2.74%
438.00
-1.79%
446.00
+8.52%
410.98
Depreciation And Amortization
450.00
+2.74%
438.00
-1.79%
446.00
+8.52%
410.98
Other Non Cash Items
645.00
-7.33%
696.00
+24.96%
557.00
+35.71%
410.44
Asset Impairment Charge
49.00
-32.88%
73.00
-27.72%
101.00
+44.32%
69.98
Operating Gains Losses
10.00
+127.78%
-36.00
+35.71%
-56.00
+46.01%
-103.73
Gain Loss On Sale Of PPE
2.00
+100.00%
1.00
-85.71%
7.00
+504.39%
-1.73
Change In Working Capital
-31.00
-234.78%
23.00
+106.34%
-363.00
+37.88%
-584.35
Change In Receivables
-32.00
+23.81%
-42.00
+39.13%
-69.00
+10.96%
-77.49
Change In Inventory
-97.00
-473.08%
26.00
+106.33%
-411.00
+34.88%
-631.12
Change In Payables And Accrued Expense
94.00
+224.14%
29.00
-72.12%
104.00
-17.80%
126.52
Change In Payable
94.00
+224.14%
29.00
-72.12%
104.00
-17.80%
126.52
Change In Other Current Assets
4.00
-60.00%
10.00
-23.08%
13.00
+677.26%
-2.25
Investing Cash Flow
-579.00
-165.35%
886.00
+324.87%
-394.00
+80.26%
-1,996.12
Cash Flow From Continuing Investing Activities
-579.00
-165.35%
886.00
+324.87%
-394.00
+80.26%
-1,996.12
Net PPE Purchase And Sale
-261.00
-24.88%
-209.00
-3.98%
-201.00
+28.34%
-280.51
Purchase Of PPE
-265.00
-13.73%
-233.00
-4.02%
-224.00
+21.07%
-283.80
Sale Of PPE
4.00
-83.33%
24.00
+4.35%
23.00
+597.82%
3.30
Capital Expenditure
-423.00
-13.71%
-372.00
-20.00%
-310.00
+21.09%
-392.87
Net Investment Purchase And Sale
-52.00
-18.18%
-44.00
+43.59%
-78.00
+52.63%
-164.66
Purchase Of Investment
-57.00
-29.55%
-44.00
+52.69%
-93.00
+43.52%
-164.66
Sale Of Investment
5.00
0.00
-100.00%
15.00
0.00
Net Business Purchase And Sale
-108.00
+62.24%
-286.00
-886.21%
-29.00
+98.11%
-1,533.26
Purchase Of Business
-108.00
+62.24%
-286.00
-886.21%
-29.00
+98.11%
-1,533.26
Net Intangibles Purchase And Sale
-158.00
-13.67%
-139.00
-61.63%
-86.00
+21.15%
-109.07
Purchase Of Intangibles
-158.00
-13.67%
-139.00
-61.63%
-86.00
+21.15%
-109.07
Net Other Investing Changes
—
1,564.00
—
91.37
Financing Cash Flow
-529.00
+61.07%
-1,359.00
-890.12%
172.00
+204.31%
-164.90
Cash Flow From Continuing Financing Activities
-529.00
+61.07%
-1,359.00
-890.12%
172.00
+204.31%
-164.90
Net Issuance Payments Of Debt
-119.00
-7.21%
-111.00
+4.31%
-116.00
-11.23%
-104.29
Repayment Of Debt
-119.00
-7.21%
-111.00
+4.31%
-116.00
-11.23%
-104.29
Long Term Debt Payments
-119.00
-7.21%
-111.00
+4.31%
-116.00
-11.23%
-104.29
Net Long Term Debt Issuance
-119.00
-7.21%
-111.00
+4.31%
-116.00
-11.23%
-104.29
Net Common Stock Issuance
—
0.00
0.00
+100.00%
-3.46
Common Stock Payments
—
0.00
0.00
+100.00%
-3.46
Common Stock Dividend Paid
-128.00
-12700.00%
-1.00
0.00
—
Cash Dividends Paid
-128.00
-12700.00%
-1.00
0.00
+100.00%
-0.59
Repurchase Of Capital Stock
—
0.00
0.00
+100.00%
-3.46
Net Other Financing Charges
-282.00
+77.39%
-1,247.00
-532.99%
288.00
+609.17%
-56.56
Changes In Cash
-61.00
-114.22%
429.00
+8680.00%
-5.00
+99.77%
-2,162.45
Effect Of Exchange Rate Changes
-94.00
-527.27%
22.00
+246.67%
-15.00
-142.19%
35.55
Beginning Cash Position
980.00
+85.26%
529.00
-3.64%
549.00
-79.49%
2,676.11
End Cash Position
825.00
-15.82%
980.00
+85.26%
529.00
-3.68%
549.21
Free Cash Flow
624.00
+17.74%
530.00
+669.89%
-93.00
+76.41%
-394.30
Earnings Losses From Equity Investments
8.00
+121.62%
-37.00
+41.27%
-63.00
+38.23%
-102.00
Interest Paid CFO
-532.00
+6.83%
-571.00
-7.94%
-529.00
-50.98%
-350.39
Interest Received CFO
10.00
-9.09%
11.00
-21.43%
14.00
+245.34%
4.05
Sale Of Business
—
—
0.00
-100.00%
91.37
Taxes Refund Paid
-169.00
+3.98%
-176.00
-10.69%
-159.00
+19.06%
-196.44
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category